SynthesisPloS one2024

Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review.

Dan-Jie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.